Investors are talking about the impact that artificial intelligence (AI) can have on their portfolios. But there's another sector offering a chance at life-changing returns. Gene editing technology is moving from hype to hope.
The seeds of gene editing technology were planted when the human genome was mapped out. Today, gene editing companies are beginning to use that knowledge to create treatments that can alter the base instructions received through DNA. This has profound implications for many illnesses and diseases with a root genetic cause. And many of the therapies being tested may be able to provide a solution with a single treatment.
What makes this sector even more appealing is that it may not only affect your financial well-being, but this technology could also save lives. However, like any sector, it's important to understand the risks involved.
In this special presentation, we're looking at seven gene editing stocks that appear to have the best chance to deliver treatments for transformational change.
Click the "Continue to Slide #1" button to view the first company.
